PG 106 TFA structure
|
Common Name | PG 106 TFA | ||
|---|---|---|---|---|
| CAS Number | 944111-22-2 | Molecular Weight | 1008.18000 | |
| Density | 1.40±0.1 g/cm3 (20 °C, 760 mmHg) | Boiling Point | N/A | |
| Molecular Formula | C51H69N13O9 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of PG 106 TFAPG106 is a potent and selective human melanocortin 3 (hMC3) receptor antagonist (IC50=210 nM) and has noactivity at hMC4 receptors (EC50=9900 nM) and hMC5 receptor[1]. |
| Name | L-Lysinamide, N-acetyl-L-norleucyl-L-α-aspartyl-β-alanyl-3-(2-naphthalenyl)-D-alanyl-L-arginyl-L-tryptophyl-, (2→7)-lactam |
|---|---|
| Synonym | More Synonyms |
| Description | PG106 is a potent and selective human melanocortin 3 (hMC3) receptor antagonist (IC50=210 nM) and has noactivity at hMC4 receptors (EC50=9900 nM) and hMC5 receptor[1]. |
|---|---|
| Related Catalog | |
| Target |
IC50: 210 nM (hMC3 receptor) EC50: 9900 nM (hMC4 receptor)[1] |
| References |
| Density | 1.40±0.1 g/cm3 (20 °C, 760 mmHg) |
|---|---|
| Molecular Formula | C51H69N13O9 |
| Molecular Weight | 1008.18000 |
| Exact Mass | 1007.53000 |
| PSA | 353.58000 |
| LogP | 4.81610 |
| InChIKey | ZFZDDBJAFMOQSH-JHMPFZGISA-N |
| SMILES | CCCCC(NC(C)=O)C(=O)NC1CC(=O)NCCCCC(C(N)=O)NC(=O)C(Cc2c[nH]c3ccccc23)NC(=O)C(CCCN=C(N)N)NC(=O)C(Cc2ccc3ccccc3c2)NC(=O)CCNC1=O |
| MMPIP hydrochloride |